crisugabalin   Click here for help

GtoPdb Ligand ID: 13764

Synonyms: HSK-16149 | HSK16149
Approved drug
crisugabalin is an approved drug
Compound class: Synthetic organic
Comment: Crisugabalin (HSK-16149) is a gabapentinoid that binds to the α2-δ subunits of voltage-gated calcium channels (encoded by the CACNA2D1 and CACNA2D2 genes), with some selectivity for the α2-δ1 channel complex [1]. It was designed for analgesic potential in chronic pain conditions.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 63.32
Molecular weight 209.29
XLogP 2.17
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1C[C@@H]2[C@@H]3C[C@H]1C[C@@H]3[C@@]2(CC(=O)O)CN
Isomeric SMILES C1C[C@@H]2[C@@H]3C[C@H]1C[C@@H]3[C@@]2(CC(=O)O)CN
InChI InChI=1S/C12H19NO2/c13-6-12(5-11(14)15)9-2-1-7-3-8(9)10(12)4-7/h7-10H,1-6,13H2,(H,14,15)/t7-,8-,9+,10-,12-/m0/s1
InChI Key WCEFMBSFXJUREW-LIJGXYGRSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Gou X, Yu X, Bai D, Tan B, Cao P, Qian M, Zheng X, Chen L, Shi Z, Li Y et al.. (2021)
Pharmacology and Mechanism of Action of HSK16149, a Selective Ligand of α2δ Subunit of Voltage-Gated Calcium Channel with Analgesic Activity in Animal Models of Chronic Pain.
J Pharmacol Exp Ther, 376 (3): 330-337. [PMID:33293377]
2. Guo X, Zhang T, Yuan G, Zeng W, Hu Q, Ma J, Li Y, Li H, Zhang Y, Liu J et al.. (2024)
GABA Analogue HSK16149 in Chinese Patients With Diabetic Peripheral Neuropathic Pain: A Phase 3 Randomized Clinical Trial.
JAMA Netw Open, 7 (8): e2425614. [PMID:39158916]
3. Zhang D, Lei T, Qin L, Li C, Lin X, Wang H, Zhang G, Zhang S, Shi K, Li L et al.. (2024)
Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical Trial.
JAMA Dermatol, 160 (11): 1182-1191. [PMID:39320907]